Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
Current Cancer Drug Targets|September 17, 2015
MYC as Therapeutic Target for Embryonal Tumors: Potential and ChallengesTarek Shalaby, Michael A GrotzerInternational Journal of Molecular Sciences|December 23, 2015
Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS MalignanciesTarek Shalaby, Michael A GrotzerMolecules (Basel, Switzerland)|May 9, 2014
Significance and therapeutic value of miRNAs in embryonal neural tumorsTarek Shalaby, Giulio Fiaschetti, Martin Baumgartner, et al.International Journal of Molecular Sciences|November 26, 2014
MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the consTarek Shalaby, Giulio Fiaschetti, Martin Baumgartner, et al.Neuro-Oncology|February 11, 2004
Telomere maintenance in childhood primitive neuroectodermal brain tumorsDomenico Didiano, Tarek Shalaby, Doris Lang, et al.Current Cancer Drug Targets|March 12, 2009
Targeting Myc in pediatric malignancies of the central and peripheral nervous systemMichael A Grotzer, Deborah Castelletti, Giulio Fiaschetti, et al.International Journal of Cancer|September 22, 2006
Protein kinase B modulates the sensitivity of human neuroblastoma cells to insulin-like growth factor receptor inhibitionAna S Guerreiro, Danielle Boller, Tarek Shalaby, et al.Molecules (Basel, Switzerland)|October 25, 2013
G-quadruplexes as potential therapeutic targets for embryonal tumorsTarek Shalaby, Giulio Fiaschetti, Kazuo Nagasawa, et al.Amino Acids|February 9, 2010
Cupiennin 1a exhibits a remarkably broad, non-stereospecific cytolytic activity on bacteria, protozoan parasites, insects, and human cancer cellsLucia Kuhn-Nentwig, Jean Willems, Thomas Seebeck, et al.Acta Neuropathologica Communications|April 9, 2014
NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastomaGiulio Fiaschetti, Christina Schroeder, Deborah Castelletti, et al.Pageof 4